These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20037568)

  • 1. [Comparative efficacy and tolerability of carbamazepine and oxcarbazepine during long therapy of patients with bipolar and schizoaffective disorders].
    Mosolov SN; Kostiukova EG; Ladyzhenskiĭ MIa
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(10):36-41. PubMed ID: 20037568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oxcarbazepine in the treatment of affective and schizoaffective disorders].
    Dietrich DE; Kropp S; Emrich HM
    Fortschr Neurol Psychiatr; 2003 May; 71(5):255-64. PubMed ID: 12740757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxcarbazepine in the treatment of bipolar and schizoaffective disorders.
    Popova E; Leighton C; Bernabarre A; Bernardo M; Vieta E
    Expert Rev Neurother; 2007 Jun; 7(6):617-26. PubMed ID: 17563245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxcarbazepine vs. valproate in the treatment of mood and schizoaffective disorders.
    Raja M; Azzoni A
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):409-14. PubMed ID: 14604456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficiency and safety of oxcarbazepine in mood disorders: a naturalistic study exploring the interest of plasma dosages.
    Misdrahi D; Tournier M; Droulout T; Grolleau A; Titier K; Molimard M; Verdoux H
    Eur Psychiatry; 2008 Sep; 23(6):409-12. PubMed ID: 18755575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode.
    Benedetti A; Lattanzi L; Pini S; Musetti L; Dell'Osso L; Cassano GB
    J Affect Disord; 2004 Apr; 79(1-3):273-7. PubMed ID: 15023507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxcarbazepine add-on in the treatment of refractory bipolar disorder.
    Pratoomsri W; Yatham LN; Sohn CH; Solomons K; Lam RW
    Bipolar Disord; 2005; 7 Suppl 5():37-42. PubMed ID: 16225559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxcarbazepine in a carbamazepine-intolerant patient with bipolar affective disorder: a case report.
    Kalra H; Dalal PK; Allet L; Janca A
    Psychiatr Danub; 2006 Jun; 18(1-2):90-1. PubMed ID: 16804505
    [No Abstract]   [Full Text] [Related]  

  • 9. [Preventive treatment of affective psychoses with finlepsin].
    Vovin RIa; Digilov AG; Skorik AI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(8):1226-30. PubMed ID: 6495947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness and safety of topiramate in treatment-resistant bipolar disorder].
    Vieta E; Gilabert A; Rodríguez A; García-Castrillón A; Luna MJ; Arrufat E; García-Parés G
    Actas Esp Psiquiatr; 2001; 29(3):148-52. PubMed ID: 11412488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two anticonvulsants in a randomized, single-blind treatment of hypomanic symptoms in patients with bipolar disorder.
    Suppes T; Kelly DI; Hynan LS; Snow DE; Sureddi S; Foster B; Curley E
    Aust N Z J Psychiatry; 2007 May; 41(5):397-402. PubMed ID: 17464731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant use of valproate and carbamazepine in bipolar and schizoaffective disorders.
    Tohen M; Castillo J; Pope HG; Herbstein J
    J Clin Psychopharmacol; 1994 Feb; 14(1):67-70. PubMed ID: 8151006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late-onset hypersensitivity reaction with leukopenia and thrombocytopenia induced by oxcarbazepine treatment in a patient with schizoaffective disorder.
    Yeh YW; Wang TY; Huang CC; Chen YC
    J Clin Psychiatry; 2008 Apr; 69(4):676-8. PubMed ID: 18507488
    [No Abstract]   [Full Text] [Related]  

  • 15. An open-label trial of adjunctive oxcarbazepine for bipolar disorder.
    Conway CR; Chibnall JT; Nelson LA; McGuire JM; Abraham PF; Baram VY; Grossberg GT; Carroll BJ
    J Clin Psychopharmacol; 2006 Feb; 26(1):95-7. PubMed ID: 16415718
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxcarbazepine in affective and schizoaffective disorders.
    Dietrich DE; Kropp S; Emrich HM
    Pharmacopsychiatry; 2001 Nov; 34(6):242-50. PubMed ID: 11778145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamazepine augmentation in lithium-refractory bipolar patients: a prospective study on long-term prophlyactic effectiveness.
    Bocchetta A; Chillotti C; Severino G; Ardau R; Del Zompo M
    J Clin Psychopharmacol; 1997 Apr; 17(2):92-6. PubMed ID: 10950470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder.
    Hirschfeld RM; Kasper S
    Int J Neuropsychopharmacol; 2004 Dec; 7(4):507-22. PubMed ID: 15458610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders.
    Emrich HM; Dose M; von Zerssen D
    J Affect Disord; 1985; 8(3):243-50. PubMed ID: 3160736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in pharmacotherapy of Schizoaffective and bipolar affective disorders: a 5-year naturalistic study.
    Fenn HH; Robinson D; Luby V; Dangel C; Buxton E; Beattie M; Kraemer H; Yesavage JA
    Am J Psychiatry; 1996 May; 153(5):711-3. PubMed ID: 8615421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.